Search Results

Filter
  • 1-10 of  216 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The p75 neurotrophin receptor as a novel intermediate in L-dopa-induced dyskinesia in experimental Parkinson's disease.

  • Authors : Liu Z; Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200082, China.; Yan A

Subjects: Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/*metabolism ; Levodopa/Levodopa/Levodopa/*toxicity ; Nerve Tissue Proteins/Nerve Tissue Proteins/Nerve Tissue Proteins/*biosynthesis

  • Source: Experimental neurology [Exp Neurol] 2021 Aug; Vol. 342, pp. 113740. Date of Electronic Publication: 2021 May 07.Publisher: Academic Press Country of Publication: United States NLM ID: 0370712 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner.

  • Authors : Hwang YP; BK21 Project Team, Department of Pharmacy, College of Pharmacy, Research Center for Proteineous Materials, Chosun University, Gwangju, South Korea.; Kim HG

Subjects: Oxidopamine*/Oxidopamine*/Oxidopamine*/antagonists & inhibitors; Heme Oxygenase-1/Heme Oxygenase-1/Heme Oxygenase-1/*biosynthesis ; NF-E2-Related Factor 2/NF-E2-Related Factor 2/NF-E2-Related Factor 2/*physiology

  • Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2008 Sep 15; Vol. 231 (3), pp. 318-27. Date of Electronic Publication: 2008 May 02.Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.

  • Authors : Nass R; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6420, USA.; Hall DH

Subjects: Membrane Glycoproteins* ; Nerve Tissue Proteins*; Dopamine/Dopamine/Dopamine/*metabolism

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2002 Mar 05; Vol. 99 (5), pp. 3264-9. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Print

Record details

×
Academic Journal

Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.

  • Authors : Fox CM; Department of Anatomy and Neurobiology, MN 225 Chandler Medical Center, University of Kentucky, Lexington 40536-0298, USA.; Gash DM

Subjects: Nerve Growth Factors* ; Oxidopamine* ; Sympatholytics*

  • Source: Brain research [Brain Res] 2001 Mar 30; Vol. 896 (1-2), pp. 56-63.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 0045503 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.

  • Authors : Eggert K; Department of Neurology, Philipps-University of Marburg, Germany. ; Schlegel J

Subjects: Drosophila Proteins* ; Nerve Growth Factors*; Cell Survival/Cell Survival/Cell Survival/*drug effects

  • Source: Neuroscience letters [Neurosci Lett] 1999 Jul 16; Vol. 269 (3), pp. 178-82.Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.

  • Authors : Cass WA; Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0298, USA.; Manning MW

Subjects: Nerve Growth Factors*; Dopamine/Dopamine/Dopamine/*biosynthesis ; Neostriatum/Neostriatum/Neostriatum/*metabolism

  • Source: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 1999 Feb 15; Vol. 19 (4), pp. 1416-23.Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

  • Authors : Kearns CM; Department of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA.; Cass WA

Subjects: Protein Biosynthesis*; Nerve Growth Factors/Nerve Growth Factors/Nerve Growth Factors/*pharmacology ; Nerve Tissue Proteins/Nerve Tissue Proteins/Nerve Tissue Proteins/*pharmacology

  • Source: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 1997 Sep 15; Vol. 17 (18), pp. 7111-8.Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine.

  • Authors : Shults CW; Veterans Affairs Medical Center, San Diego, CA 92161, USA.; Kimber T

Subjects: Nerve Growth Factors*; Neostriatum/Neostriatum/Neostriatum/*physiology ; Nerve Tissue Proteins/Nerve Tissue Proteins/Nerve Tissue Proteins/*pharmacology

  • Source: Neuroreport [Neuroreport] 1996 Jan 31; Vol. 7 (2), pp. 627-31.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100935 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.

Subjects: Corpus Striatum/Corpus Striatum/Corpus Striatum/*drug effects ; Nerve Growth Factors/Nerve Growth Factors/Nerve Growth Factors/*pharmacology ; Nerve Tissue Proteins/Nerve Tissue Proteins/Nerve Tissue Proteins/*pharmacology

  • Source: Neuroreport [Neuroreport] 1995 Dec 29; Vol. 7 (1), pp. 348-52.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100935 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Ganglioside GM1 cooperates with brain-derived neurotrophic factor to protect dopaminergic neurons from 6-hydroxydopamine-induced degeneration.

  • Authors : Fadda E; Fidia Research Laboratories, Abano Terme, Italy.; Negro A

Subjects: Dopamine/Dopamine/Dopamine/*physiology ; G(M1) Ganglioside/G(M1) Ganglioside/G(M1) Ganglioside/*physiology ; Nerve Growth Factors/Nerve Growth Factors/Nerve Growth Factors/*physiology

  • Source: Neuroscience letters [Neurosci Lett] 1993 Sep 03; Vol. 159 (1-2), pp. 147-50.Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  216 results for ""Oxidopamine""